
Obesity-related cancers on the rise amongst millennials
pharmafile | February 4, 2019 | News story | Sales and Marketing |Â Â Cancer, obesity, oncology, young peopleÂ
Cancers related to obesity are on the rise in young adults, according to findings from the American Cancer Society, published in The Lancet Public Health.
The incidence of six of 12 obesity-related cancers increased significantly between 1995 and 2014, in young adults aged between 25 and 49. Meanwhile, the incidence rate increased more sharply in successively young generations.
Multiple myeloma, colorectal, uterine corpus, gallbladder, kidney, and pancreatic cancer were all on the rise in young adults, particularly among those in their 20s and 30s.
However, rates of obesity related cancers also rose among older adults as well. Nevertheless the magnitude of these increases was smaller in older people than in young adults.
The findings come as prevalence of obesity increased by more than 100% between 1980 and 2014 among children and young adults, and by 60% among adults aged 20-74 years old.
On the other hand, prevalence of eight of 18 cancers not linked to obesity decreased among young people. Cancers linked to smoking and HIV-infection were both on the decline as just two cancers not related to obesity (gastric non-cardia cancer and leukaemia) increased among young people.
Louis Goss
Related Content

Survodutide delivers up to 13.1% weight loss in phase 3 obesity and diabetes trial
Boehringer Ingelheim’s investigational survodutide produced weight loss of up to 13.1% after 76 weeks in …

AI in pharma: From lab development to patient impact
In the decade to 2025, AI use in vaccine development has increased markedly but is …

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer
Bristol Myers Squibb (BMS) has announced that its Opdivo (nivolumab) has been accepted, in combination …






